Immunodermatology News

Enanthemas were commonly reported among patients with non-classic forms of pityriasis rosea, including persistent and pediatric forms of the disease.

This week, Genentech announced its phase 3 trial of Actemra for patients with systemic sclerosis has completed enrollment. The study will compare the drug’s safety and efficacy with placebo in patients with systemic sclerosis, according to a press release.

Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles in July on Healio.com/Dermatology.

Patients with lung cancer who were received immunotherapy experienced hair repigmentation, with the majority also experiencing good clinical response, according to recently published study results in JAMA Dermatology.

Study results showing minimal to no transfer of Cimzia from mother's plasma to breast milk was a top-read article of the past week on Healio.com/Dermatology.

Recent FDA actions have included approving Juvéderm Vollure XC for treating nasolabial folds with results up to 18 months and the addition of fingernail psoriasis data to Humira prescribing information.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Amy J. McMichael, MD, FAAD, discusses the Skin of Color Society.

The American Academy of Dermatology announced the results of its annual election, including Jane M. Grant-Kels, MD, FAAD, as vice president-elect and four new board members.

The American Academy of Dermatology announced that George J. Hruza, MD, MBA, FAAD, has been elected president-elect of the academy.

Patients with mild lupus had increased insulin resistance and hyperglucagonemia, while having normal glucose tolerance and a preserved beta-cell function and skeletal muscle GLUT-4 translocation, according to recently published data.